Natural Killer Cells Show Promise in Alzheimer’s Trials

Digital Behavioral Therapy for Fibromyalgia

In episode 3, we’ll be talking about the behind-the-scenes process of developing a digital therapeutic–from selecting a disease focus area to developing prospective evidence. You’ll also learn about patient recruitment, decentralization strategies, working with the FDA, and successful commercialization tactics.

Natural Killer Cells Show Promise in Alzheimer’s Trials

In episode 2 of “Trial Trailblazers,” learn about a novel treatment using natural killer cells to treat Alzheimer’s disease. Get a behind-the-scenes look at some remarkable benefits of this treatment and hear about the journey that involved receiving compassionate use approval from the FDA, navigating funding, and turning promising science into fast-tracked clinical trials.

Pioneering Treatments for Rare Pediatric Diseases

In Episode 1 of “Trial Trailblazers,” explore the challenges of developing treatments for rare pediatric diseases.